Asthma
Assessing unmet needs in chronic respiratory disease management …from the patient’s perspective
Despite advances in asthma management, morbidity is still high across Europe.1 Many patients regard their asthma as being controlled, despite experiencing symptoms and exacerbations.2 However, findings have shown that patients who are better educated on their disease have improved asthma control.3–5
In recent years, findings have shown that patients who practice supported self-management of their disease have lower use of healthcare resources and an improved quality of life.6 This could mean that healthcare professionals may choose to use more innovative ways of improving patient’s quality of life in the future. One way that this could be achieved is by adopting the use of digital devices (to provide interactive interventions involving two-way responsive patient communication) that can lead to improvements in adherence to medication and patient’s impairment due to asthma.7
Watch the video below to learn more from Monica Fletcher about the importance of patient empowerment and self-management in asthma.
Let’s Talk Respiratory is organised and funded by Teva Pharmaceuticals Europe B.V and intended for healthcare professionals only. Views provided by speakers are their own and not necessarily shared by Teva Pharmaceuticals. Information in the video/article may discuss drug classes where Teva have a product and products that are not authorised in all countries. Please consult local prescribing information.
Approval code: RESP-TPE-NP-00312 Date of preparation: October 2022
References
- Lung Facts Resource (Asthma). International Respiratory Coalition 2022. Available online: https://international-respiratory-coalition.org/diseases/asthma/ (accessed October 2022)
- Price D, et al. NPJ Prim Care Respir Med 2014;24:14009
- Mishra R, et al. Can Respir J 2017;5681962
- Plaza V, et al. Eur Respir J 2015;46:1298–1307
- Dailah HG. Front Public Health 2021;9:736203
- Hodkinson A, et al. BMJ 2020;370:m2521
- Mosnaim G, et al. J Allergy Clin Immunol Pract 2021;9:2377–98